kuwanon G T3S1612
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
1. Kuwanon G as dual inhibitors of PTP1B and _-glucosidase enzymes, as well as insulin sensitizers, it may potentially be utilized as an effective treatment for Type II diabetes mellitus. 2. Kuwanon G has anti-inflammatory activity, it can attenuate ather
CAS nr:
75629-19-5
Purity:
98%
Molecular Weight:
692,7
SMILES:
C\C(C)=C\Cc1c(oc2c([C@H]3C=C(C)C[C@H]([C@@H]3C(=O)c3ccc(O)cc3O)c3ccc(O)cc3O)c(O)cc(O)c2c1=O)-c1ccc(O)cc1O
Formula:
C40H36O11
Pathway:
Metabolism,Neuroscience,Neuroscience,Microbiology/Virology,Metabolism,GPCR/G Protein
Target:
Glucokinase,AChE,AChR,Antibacterial,Phosphatase,Bombesin Receptor
